EN zh-TW

newsio aggregates and links to original sources. We do not own the original images or content. If you believe content infringes on intellectual property rights, contact us — it will be removed at first notice.

biotech / news / / Seeking Alpha

Novo Nordisk is losing GLP-1 and diabetes market share in key regions.

Novo Nordisk is losing U.S. diabetes and obesity market share to Eli Lilly's Zepbound and Mounjaro.

KEY POINTS
COMPANIES
Read the full story on Seeking Alpha → →
Share X LinkedIn

Summarized by Newsio from Seeking Alpha. How we summarize →

RELATED 03
biotech · news · 1h 202

Cancer cells can stay hidden in the body for years before causing a relapse.

  • Breast cancer cells mimic healthy stem cells to survive undetected in bone marrow niches.
  • Notch2, but not Notch1, plays a significant role in inducing dormancy within breast cancer cells.
Drug Target Review →
biotech · news · 10h 203

Meningioma is the most common brain tumor in adults.

  • Mayo Clinic's study mapped over 500,000 individual meningioma tumor cells using single-cell sequencing.
  • Distinct immune cell states in the tumor microenvironment predict aggressiveness and recurrence risk.
News-Medical →
biotech · news · 13h 202

Scientists who study the Y chromosome expect to find a record of loss.

  • Researchers discovered a gene, Phf8y, that moved onto and duplicated within the deer mouse Y chromosome.
  • This is the first known example of a gene completing a full move onto the mammalian Y chromosome.
Earth.com →